Navigation Links
BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results
Date:3/15/2010

PLYMOUTH MEETING, Pa., March 15 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company") today announced financial results for the fourth quarter and fiscal year ended December 31, 2009.

    Fourth Quarter 2009 Financial Highlights:
    -- Revenue increased to $41.5 million, from $36.6 million in the fourth
       quarter of 2008;
    -- Gross profit increased 21% to $23.3 million, from $19.2 million in the
       fourth quarter of 2008;
    -- Gross margin increased to 56.1% from 52.4% in the prior year period;
    -- Operating income increased to $4.0 million from $1.8 million in the
       prior year period;
    -- Adjusted EBITDA, as defined below, was $5.5 million for the quarter, up
       69% on a year over year basis.

    Full Year 2009 Financial Highlights:
    -- Revenue increased 28% to $146.9 million, from $114.9 million in 2008;
    -- Gross profit increased 29% to $74.0 million, from $57.3 million in 2008;
    -- Gross margin increased to 50.4% from 49.9% on a year over year basis;
    -- Operating income increased to $8.4 million from $3.7 million in the
       prior year period;
    -- Adjusted EBITDA, as defined below, was $14.4 million for the year 2009,
       up 36% on a year over year basis.

David Gao, Chief Executive Officer of BMP Sunstone, stated, "We achieved a record year in 2009 and we are proud of the progress we have made across our operating segments, all of which were profitable on an operating basis by the en
'/>"/>

SOURCE BMP Sunstone Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. BMP Sunstone to Report Fourth Quarter and Full Year 2009 Financial Results
2. BMP Sunstone Reports Third Quarter 2009 Financial Results
3. BMP Sunstone to Report Third Quarter 2009 Financial Results
4. BMP Sunstone Announces November Investor Conference Participation
5. BMP Sunstone Appoints Daniel Harrington to Board of Directors
6. BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results
7. BMP Sunstone to Present at UBS Global Healthcare Services Conference
8. BMP Sunstone Adopts Voluntary Executive Compensation Restrictions in 2008 and 2009
9. BMP Sunstone Receives High Tech Status
10. BMP Sunstone to Present at the 20th Annual Piper Jaffray Health Care Conference
11. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... EPFL and the University of  Geneva ... John P. Donoghue . The American neuroscientist is ... . The new Wyss Center for Bio- ... Geneva , has named as its director one ... Donoghue , founder of Brown University,s Institute for Brain ...
(Date:7/10/2014)... 10, 2014 Women in the ... to an additional family planning option. Sayana® Press ... at all levels of the health system and ... a widely used contraceptive—Pfizer’s Depo-Provera® (depot medroxyprogesterone acetate)—with ... is the first of four African countries expected ...
(Date:7/10/2014)... 10, 2014 Terascala, the industry leader ... Alan Swahn, a former vice president of product management ... vice president of marketing. Terascala’s software when combined with ... create the highest performance and most reliable solutions for ... guide Terascala’s channel expansion and broaden its product portfolio. ...
(Date:7/10/2014)... EvoDerma ’s NOOME Anti-Aging Motion has been ... comes with a second treatment cup to help prevent and ... cup is thinner on the edges for a softer contact ... and uneven surfaces on the face, neck and décolleté. Choose ... on areas such as the cheeks and neck, or opt ...
Breaking Biology Technology:John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 2John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6Terascala Expands Executive Team 2Terascala Expands Executive Team 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2
... SAN DIEGO, March 3, 2011 Anadys Pharmaceuticals, Inc. (Nasdaq: ... patient care by developing novel medicines for the treatment of ... for the fourth quarter and year ended December 31, 2010. ... well-positioned to create value in the evolving HCV landscape," said ...
... 2011 Novavax, Inc. (Nasdaq: NVAX ) ... visit the company,s headquarters in Rockville, Maryland, on Monday, ... at up to $179 million. The Office of Biomedical ... of the Assistant Secretary for Preparedness and Response at ...
... Executive search firm Sanford Rose Associates® - Minneapolis ... engagement for Nordson Corporation: Lise W. Duran as General ... of biomaterial applicators used in a wide variety of ... years of experience in the medical device industry, having ...
Cached Biology Technology:Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights 2Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights 3Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights 4Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights 5Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights 6Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights 7Maryland Governor Martin O'Malley to Visit Novavax in Celebration of HHS-BARDA Contract Award 2Maryland Governor Martin O'Malley to Visit Novavax in Celebration of HHS-BARDA Contract Award 3Maryland Governor Martin O'Malley to Visit Novavax in Celebration of HHS-BARDA Contract Award 4Sanford Rose Associates® - Minneapolis Fills Key Management Position for the Micromedics Operation of Nordson Corporation 2
(Date:7/10/2014)... , July 7, 2014 Fingerprint Cards, ... major design win (DW). A Chinese Top 5 smartphone OEM ... start of mass production in October 2014.   ... Top 5 smartphone OEM, which has a planned date for ... target sales volume for this phone of 3 million units. ...
(Date:7/10/2014)... GOTHENBURG, Sweden , July 8, 2014 ... FPC1021 has won a new design win (DW). An Asian ... targeted date for mass production start in August 2014.   ... an Asian smartphone OEM, which has a planned date for ... received an initial ramp order of SEK 5M, for delivery ...
(Date:7/10/2014)... Ill. , July 9, 2014 ... (EHR), spurred in large part by meaningful use ... health care providers interact with laboratory information. Now, ... in the field of clinical informatics in order ... To address the educational needs of ...
Breaking Biology News(10 mins):FPC Wins DW for 1021 Touch Sensor for Flagship Smartphone from Chinese Top 5 Smartphone OEM 2FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM 2New Clinical Informatics Curriculum Prepares Future Pathologists 2New Clinical Informatics Curriculum Prepares Future Pathologists 3New Clinical Informatics Curriculum Prepares Future Pathologists 4
... Marta Barrachina, Institute of Neuropathology of the Bellvitge Biomedical ... patients suffering from schizophrenia characterized by motor disorders. ... collaboration with the research team Mairena Martin at the ... clinical researchers of the Health Park Sant Joan de ...
... The Clinical Nutrition Research Centre (CNRC) -- a ... and Research (A*STAR) and National University Health Systems (NUHS) ... that will conduct nutritional studies to understand the causes ... develop products and formulate diets that can reduce the ...
... LAKE CITY, Utah, Jan. 29, 2014 Myriad Genetics, ... a clinical utility study with its Prolaris test, at ... Calif. The study demonstrated the significant clinical value ... prostate cancer. Prolaris is a prognostic test that ...
Cached Biology News:Identified a subgroup of schizophrenia patients with motor disorders 2Asia's first under-1-roof Nutritional Research Centre set up in Singapore 2Asia's first under-1-roof Nutritional Research Centre set up in Singapore 3Asia's first under-1-roof Nutritional Research Centre set up in Singapore 4Myriad's Prolaris significantly modifies treatment decisions for prostate cancer patients 2